12,826
Total Publications
431,355
Total Citations
Top Researchers
- José M. Marı́n 29,597 citations • 456 papers
- Javier García‐Campayo 18,703 citations • 631 papers
- Carlos Martı́n 17,403 citations • 395 papers
- Á. Artal 12,844 citations • 149 papers
- Fernando Civeira 12,474 citations • 498 papers
- Stacey W. Martin 12,280 citations • 159 papers
- Javier Sanz 12,064 citations • 371 papers
- Santiago Carrizo 11,014 citations • 67 papers
- Roberto Pazo-Cid 9,146 citations • 128 papers
- Martin Gutierrez 8,688 citations • 488 papers
Most Cited Papers
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial 2012 • 5,505 citations
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study 2005 • 4,624 citations
- The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease 2004 • 4,017 citations
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial 2021 • 2,797 citations
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial 2016 • 2,789 citations
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study 2005 • 1,861 citations
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial 2006 • 1,581 citations
- The role of probiotics in aquaculture 2006 • 1,316 citations
- Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease 2012 • 1,262 citations
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial 2012 • 1,160 citations